Documentos relacionados

1. Direct activation of microglia by ß-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher disease.
2. The D409H variant in GBA1: Challenges in predicting the Gaucher phenotype in the newborn screening era.
3. Revisiting the diagnosis of Gaucher disease in a family with multiple GBA1 variants.
4. Clinical Characteristics and GBA Gene Mutation Analysis of Gaucher Disease Type I.
5. [Gaucher disease: achievements and prospects].
6. Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.
7. Long-term follow-up of a patient with neonatal form of Gaucher disease.
8. The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
9. Diagnosis, treatment and genetic analysis of an elderly patient with Gaucher's disease characterized by marked multiple bone destruction.
10. Patient reported outcomes of patients with Gaucher disease type 1 treated with eliglustat in real-world settings: The ELIPRO study.